Pekin Hardy Strauss’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
Pekin Hardy Strauss's CLPT Position: Q3 2026 in Review
Pekin Hardy Strauss increased its ClearPoint Neuro (CLPT) stake by 94% in Q3 2026, buying an estimated $2.02M and bringing the position to 277,915 shares worth $3.39M. The position accounts for 0.3% of the portfolio, ranked #87.
Pekin Hardy Strauss first reported a position in CLPT in Q3 2024 and has held it in 7 quarters since. 126 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.
- Pekin Hardy Strauss held 277,915 shares of ClearPoint Neuro worth $3.39M as of Q3 2026.
- Pekin Hardy Strauss bought 134,540 ClearPoint Neuro shares in Q3 2026, an estimated $2.02M.
- ClearPoint Neuro made up 0.3% of Pekin Hardy Strauss's portfolio in Q3 2026, its #87 holding.
- Pekin Hardy Strauss first reported a position in ClearPoint Neuro in Q3 2024 and has held it in 7 quarters since.
- 126 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.
Based on Pekin Hardy Strauss's 13F filing for Q3 2026, filed 2 Nov 2026.